Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Fuenlabrada
Clinical trial register · Spain

Clinical Trials in Fuenlabrada, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie3 Novo Nordisk A/S2 Abivax S.A.2 Eli Lilly and Company2 Universidad Rey Juan Carlos2
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Fuenlabrada

26 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Novo Nordisk A/S
Phase 3
450
Fuenlabrada, Almería, Castilleja de la Cuesta, Ferrol, Madrid, Santiago de Compostela, Seville
2026-08-12
Recruiting
Universidad Rey Juan Carlos
Not applicable
100
Fuenlabrada
2026-05-10
Not yet open
Universidad de Granada
Phase 2/3
740
Granada, Motril, Fuenlabrada, Madrid, Melilla
2026-05
By invitation
Caffeine Strategies and Fat Oxidation
NCT07402902Fat Metabolism, Caffeine, Cycling, Exercise
DrugCaffeine
Universidad Rey Juan Carlos
Not applicable
10
Fuenlabrada
2026-03-15
Recruiting
UNICANCER
Phase 3
3,902
Badajoz, Barcelona, Bilbao, Fuenlabrada, Granada, Jaén, Jerez de la Frontera, L'Hospitalet de Llobregat
2025-12-18
Recruiting
Eli Lilly and Company
Phase 2
252
Barcelona, Fuenlabrada, Gijón, Madrid
2025-11-10
Recruiting
Abivax S.A.
Phase 2
212
Barcelona, Córdoba, Fuenlabrada, Huelva, Las Palmas de Gran Canaria, Santiago de Compostela, Seville, Valencia
2024-10-30
Recruiting
PEACHES BIOTECH
Phase 1/2
50
Alcalá de Henares, Fuenlabrada, Córdoba
2024-10-02
Recruiting
Fundación Sociedad Española de Oncologia Médica
Observational
540
Santander, Ciudad Real, Cuenca, Alicante, Arganda, Fuencarral-El Pardo, Fuenlabrada, Salamanca
2024-09-12
Active, closed
POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol After Gastric Surgery (POWER 4 + 3)
NCT06790238Adenocarcinoma of Stomach, Critical Pathways, Enhanced Recovery After Surgery (ERAS) Protocol, Retrospective Studies
Grupo Español de Rehabilitación Multimodal
Observational
350
Alcázar de San Juan, Barakaldo, Barcelona, Bilbao, Ciudad Real, Fuenlabrada, Guadalajara, Inca
2024-09-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Badalona, Terrassa, Galdakao-Usansolo, Fuenlabrada, Madrid, Torrejón de Ardoz, Valencia
2023-10-25
Recruiting
AbbVie
Phase 3
1,500
L'Hospitalet de Llobregat, Fuenlabrada, Barcelona, Córdoba, Madrid, Valencia
2023-10-11
Recruiting
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
NCT05781217Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence, Androgen Deprivation Therapy
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Phase 3
534
L'Hospitalet de Llobregat, Fuenlabrada, Pozuelo de Alarcón, Barakaldo, Barcelona, Madrid, Tarragona, Valencia
2023-03-14
Recruiting
High Definition Medicine for Solid Tumors Oncology
NCT06590506Metastatic Solid Tumor, Advanced Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III
Observational
300
A Coruña, Fuenlabrada, Palma de Mallorca, Pamplona, Seville, Barcelona, Cáceres, Madrid
2023-03-02
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Fuenlabrada, Alzira, Antequera, Barcelona, Castilleja de la Cuesta, Córdoba, Las Palmas de Gran Canaria, Madrid
2023-03-01
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Córdoba, Santiago de Compostela, Las Palmas de Gran Canaria, Fuenlabrada, Barcelona, Girona, Huelva, Madrid
2023-01-16
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Albacete, Alicante, Badajoz, Barcelona, Cáceres, Córdoba, El Palmar, Fuenlabrada
2022-12-16
Active, closed
SOLTI Breast Cancer Research Group
Phase 2
120
Badalona, Santa Cruz de Tenerife, A Coruña, Fuenlabrada, Móstoles, Badajoz, Barcelona, Bilbao
2022-11-25
Recruiting
AbbVie
Phase 3
768
Las Palmas de Gran Canaria, Alcorcón, Fuenlabrada, Ávila, Barcelona, Jaén, Madrid, Valencia
2022-03-25
Active, closed
AbbVie
Phase 3
527
Ferrol, Santiago de Compostela, Badalona, L'Hospitalet de Llobregat, Fuenlabrada, Majadahonda, Oviedo, Alicante
2020-09-30
Active, closed
Amgen
Phase 3
145
Granada, Seville, Salamanca, Barcelona, Ourense, Fuenlabrada, Castellon, Madrid
2020-02-26
Recruiting
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
NCT04075084Tachycardia, Atrial Fibrillation, Syncope, Bradycardia
Biotronik SE & Co. KG
Observational
1,400
Erandio, Fuenlabrada, Vigo, Vitoria-Gasteiz
2019-10-28
Active, closed
Eli Lilly and Company
Phase 3
1,058
Alicante, Fuenlabrada, Girona, Huelva, Las Palmas de GC, Madrid, Oviedo, Sagunto
2018-07-18
Active, closed
Janssen Biotech, Inc.
Observational
535
A Coruña, Barcelona, Córdoba, Fuenlabrada, Huelva, Madrid, Majadahonda, San Sebastián de los Reyes
2016-12-16
Recruiting
Spanish Breast Cancer Research Group
Observational
1,867
Elche, Manresa, Terrassa, San Sebastián, Las Palmas de Gran Canaria, Alcorcón, Fuenlabrada, Leganés
2016-08
Active, closed
Hoffmann-La Roche
Phase 2
534
Fuenlabrada, Barcelona, Madrid, Málaga, Seville
2015-11-19
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/fuenlabrada

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Fuenlabrada.

How many clinical trials are recruiting in Fuenlabrada?

14 of the 26 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 10 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Fuenlabrada), 26 studies
PhaseStudiesRecruitingShare
Phase 312646.2%
Observational6423.1%
Phase 24215.4%
Not applicable217.7%
Phase 1/2113.8%
Phase 2/3103.8%

Most active sponsors

Lead sponsors with the most studies (Fuenlabrada)
Lead sponsorStudiesRecruiting
AbbVie32
Abivax S.A.21
Eli Lilly and Company21
Novo Nordisk A/S21
Universidad Rey Juan Carlos21
Amgen10
Biotronik SE & Co. KG11
Centro Nacional de Investigaciones Oncologicas CARLOS III11
Fundación Sociedad Española de Oncologia Médica11
Greenwich LifeSciences, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.